Platford Giles Richard

President, IBU at TAK

Sold, on record
$532k
Dollars the filings state
Form 4 sales
1
Latest Aug 10, 2026
Form 144 notices
6
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • TAKTAKEDA PHARMACEUTICAL CO LTDPresident, IBU

Sales by reason

0
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice TAKNotice
    Jul 10, 2023 2023

    Filed to sell 24,394 shares ($378k)

    Platford Giles Richard, President, Plasma-Derived Therapies Business Unit

    No 10b5-1 planFirst sale on recordFiling

  2. 2 Form 144 notice TAKNotice
    Jul 10, 2024 +366 days

    Filed to sell 20,721 shares ($273k)

    Platford Giles Richard, President, Plasma-Derived Therapies Business Unit

    No 10b5-1 planFirst sale on recordFiling

  3. 3 Form 144 notice TAKNotice
    Aug 22, 2024 +43 days

    Filed to sell 19,073 shares ($285k)

    Platford Giles Richard, President, Plasma-Derived Therapies Business Unit

    No 10b5-1 planFirst sale on recordFiling

  4. 4 Form 144 notice TAKNotice
    Jul 9, 2025 +321 days

    Filed to sell 28,552 shares ($440k)

    Platford Giles Richard, President, Plasma-Derived Therapies Business Unit

    No 10b5-1 planFirst sale on recordFiling

  5. 5 Form 144 notice TAKNotice
    Dec 4, 2025 +148 days

    Filed to sell 58,421 shares ($836k)

    Platford Giles Richard, President, Plasma-Derived Therapies Business Unit

    No 10b5-1 planFirst sale on recordFiling

  6. 6 Form 144 notice TAKNotice
    Jul 13, 2026 +221 days

    Filed to sell 33,696 shares ($564k)

    Platford Giles Richard, President, International Business Unit

    No 10b5-1 planFirst sale on recordFiling

  7. 7 Form 4 sale TAKNo plan
    Aug 10, 2026 +28 days

    Sold 31,083 shares at $17.10 ($532k)

    Platford Giles Richard, President, IBU

    No 10b5-1 planSold 9% of holdings ($5.9M position)315,838 shares leftFirst sale on recordFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (7)

Form 144 notices and Form 4 sales by Platford Giles Richard
Source
Aug 10, 2026Aug 12, 2026TAKPresident, IBUForm 4 sale31,083$532k9.0%No planSEC
Jul 13, 2026Jul 13, 2026TAKPresident, International Business UnitForm 144 notice33,696$564kNoticeSEC
Dec 4, 2025Dec 4, 2025TAKPresident, Plasma-Derived Therapies Business UnitForm 144 notice58,421$836kNoticeSEC
Jul 9, 2025Jul 9, 2025TAKPresident, Plasma-Derived Therapies Business UnitForm 144 notice28,552$440kNoticeSEC
Aug 22, 2024Aug 22, 2024TAKPresident, Plasma-Derived Therapies Business UnitForm 144 notice19,073$285kNoticeSEC
Jul 10, 2024Jul 10, 2024TAKPresident, Plasma-Derived Therapies Business UnitForm 144 notice20,721$273kNoticeSEC
Jul 10, 2023Jul 10, 2023TAKPresident, Plasma-Derived Therapies Business UnitForm 144 notice24,394$378kNoticeSEC